Placebo-controlled study of the D4/5-HT(2A) antagonist fananserin in the treatment of schizophrenia

Philippe Truffinet, Carol A. Tamminga, Louis F. Fabre, Herbert Y. Meltzer, Marie Emmanuelle Rivière, Catherine Papillon-Downey

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Placebo-controlled study of the D<sub>4</sub>/5-HT(2A) antagonist fananserin in the treatment of schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences